Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 23.57 Million USD | -17.91% |
| 2022 | 28.71 Million USD | -8.35% |
| 2021 | 31.33 Million USD | -76.22% |
| 2020 | 131.77 Million USD | 8.43% |
| 2019 | 121.52 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 18.69 Million USD | -20.69% |
| 2024 Q2 | 19.74 Million USD | 5.6% |
| 2024 Q3 | 20.64 Million USD | 4.54% |
| 2023 Q2 | 20.72 Million USD | -10.44% |
| 2023 Q3 | 22.62 Million USD | 9.17% |
| 2023 Q4 | 23.57 Million USD | 4.19% |
| 2023 Q1 | 23.14 Million USD | -19.41% |
| 2023 FY | 23.57 Million USD | -17.91% |
| 2022 Q2 | 30.21 Million USD | 3.69% |
| 2022 FY | 28.71 Million USD | -8.35% |
| 2022 Q4 | 28.71 Million USD | -12.87% |
| 2022 Q3 | 32.96 Million USD | 9.1% |
| 2022 Q1 | 29.13 Million USD | -7.01% |
| 2021 FY | 31.33 Million USD | -76.22% |
| 2021 Q1 | 62.86 Million USD | -52.29% |
| 2021 Q2 | 67.94 Million USD | 8.07% |
| 2021 Q3 | 42.07 Million USD | -38.08% |
| 2021 Q4 | 31.33 Million USD | -25.53% |
| 2020 Q2 | -36.38 Thousand USD | -706.42% |
| 2020 Q1 | 6000.00 USD | 0.0% |
| 2020 FY | 131.77 Million USD | 8.43% |
| 2020 Q4 | 131.77 Million USD | 0.0% |
| 2020 Q3 | - USD | 100.0% |
| 2019 FY | 121.52 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 99.046% |
| Addus HomeCare Corporation | 317.73 Million USD | 92.58% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | 81.804% |
| Amedisys, Inc. | 940.38 Million USD | 97.493% |
| American Oncology Network, Inc. | 368.72 Million USD | 93.606% |
| Astrana Health, Inc. | 522.59 Million USD | 95.489% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 98.664% |
| IMAC Holdings, Inc. | 1.89 Million USD | -1142.905% |
| biote Corp. | 191.84 Million USD | 87.711% |
| Cryo-Cell International, Inc. | 72.25 Million USD | 67.371% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | 88.552% |
| COMPASS Pathways plc | 50.24 Million USD | 53.078% |
| DocGo Inc. | 185.28 Million USD | 87.276% |
| The Ensign Group, Inc. | 2.68 Billion USD | 99.12% |
| Healthcare Services Group, Inc. | 346.56 Million USD | 93.198% |
| InnovAge Holding Corp. | 247.85 Million USD | 90.488% |
| Assure Holdings Corp. | 22.84 Million USD | -3.177% |
| The Joint Corp. | 62.37 Million USD | 62.207% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 97.069% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -518.578% |
| ModivCare Inc. | 1.61 Billion USD | 98.537% |
| NewGenIvf Group Limited | 1.24 Million USD | -1799.012% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -113.079% |
| Option Care Health, Inc. | 1.9 Billion USD | 98.764% |
| P3 Health Partners Inc. | 427.3 Million USD | 94.483% |
| P3 Health Partners Inc. | 427.3 Million USD | 94.483% |
| The Pennant Group, Inc. | 394.17 Million USD | 94.019% |
| Surgery Partners, Inc. | 3.65 Billion USD | 99.355% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -2490.454% |
| Talkspace, Inc. | 23.57 Million USD | 0.0% |
| The Oncology Institute, Inc. | 162.39 Million USD | 85.483% |
| The Oncology Institute, Inc. | 162.39 Million USD | 85.483% |